<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/cito/cites>	<http://dx.doi.org/10.1016/j.tips.2004.04.001> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/cito/cites>	<http://dx.doi.org/10.1016/j.ijid.2020.03.004> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/pro/creator>	<https://orcid.org/0000-0002-2588-9366> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/spar/fabio/JournalArticle> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/cito/cites>	<http://dx.doi.org/10.1615/critrevtherdrugcarriersyst.v26.i6.10> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/spar/fabio/Work> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/cito/cites>	<http://dx.doi.org/10.1155/2017/5279065> .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/dc/terms/identifier>	"905850c19d1857fb4ed59450af09b005e26affd4" .
<http://dx.doi.org/10.1080/21645515.2020.1758534>	<http://purl.org/spar/pro/creator>	<https://orcid.org/0000-0002-2729-2133> .